APA

Cushman W. C., Bakris G. L., White W. B., Weber M. A., Sica D., Roberts A., Lloyd E. & Kupfer S. (20121213). Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. : Hypertension (Dallas, Tex. : 1979).

Chicago

Cushman William C, Bakris George L, White William B, Weber Michael A, Sica Domenic, Roberts Andrew, Lloyd Eric and Kupfer Stuart. 20121213. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. : Hypertension (Dallas, Tex. : 1979).

Harvard

Cushman W. C., Bakris G. L., White W. B., Weber M. A., Sica D., Roberts A., Lloyd E. and Kupfer S. (20121213). Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. : Hypertension (Dallas, Tex. : 1979).

MLA

Cushman William C, Bakris George L, White William B, Weber Michael A, Sica Domenic, Roberts Andrew, Lloyd Eric and Kupfer Stuart. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. : Hypertension (Dallas, Tex. : 1979). 20121213.